The loss of functional active Hsp90 multichaperone complexes in cancer cells elicit an HSF1-dependent anti-stress response, which confers cell resistance and offsets the cytocidal effects of Hsp90 inhibitors [67,85]. Here, HSF1 is linked to cancer.